Literature DB >> 11561031

The effect of non-invasive positive pressure ventilation (NIPPV) on cognitive function in amyotrophic lateral sclerosis (ALS): a prospective study.

I C Newsom-Davis1, R A Lyall, P N Leigh, J Moxham, L H Goldstein.   

Abstract

OBJECTIVES: Neuropsychological investigations have shown a degree of cognitive dysfunction in a proportion of non-demented patients with ALS. Respiratory muscle weakness in ALS can lead to nocturnal hypoventilation, resulting in sleep disturbance and daytime somnolence. Sleep deprivation of this type may cause impairments in cognitive function, but this has not been formally evaluated in ALS.
METHODS: Cognitive functioning was evaluated in nine patients with ALS with sleep disturbance caused by nocturnal hypoventilation (NIPPV group), and in a comparison group of 10 similar patients without ventilation problems (control group). The NIPPV group then started non-invasive positive pressure ventilation (NIPPV) at night. After about 6 weeks, change in cognitive function was evaluated.
RESULTS: Statistically significant improvement in scores on two of the seven cognitive tests was demonstrated in the NIPPV group postventilation, and a trend towards significant improvement was found for two further tests. Scores in the control group did not improve significantly for these four tests, although an improvement was found on one other test.
CONCLUSIONS: Nocturnal hypoventilation and sleep disturbance may cause cognitive dysfunction in ALS. These deficits may be partially improved by NIPPV over a 6 week period. This has important implications for investigations of both cognitive dysfunction in non-demented patients with ALS, and the effect of ventilation on quality of life.

Entities:  

Mesh:

Year:  2001        PMID: 11561031      PMCID: PMC1763518          DOI: 10.1136/jnnp.71.4.482

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  34 in total

1.  Sleep, respiration and ALS.

Authors:  L S Aboussouan; R A Lewis
Journal:  J Neurol Sci       Date:  1999-03-15       Impact factor: 3.181

2.  Frontal lobe dysfunction in amyotrophic lateral sclerosis. A PET study.

Authors:  S Abrahams; L H Goldstein; J J Kew; D J Brooks; C M Lloyd; C D Frith; P N Leigh
Journal:  Brain       Date:  1996-12       Impact factor: 13.501

3.  Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS).

Authors:  S Abrahams; P N Leigh; A Harvey; G N Vythelingum; D Grisé; L H Goldstein
Journal:  Neuropsychologia       Date:  2000       Impact factor: 3.139

4.  Neuropsychological study of motor neuron disease.

Authors:  A S David; R A Gillham
Journal:  Psychosomatics       Date:  1986-06       Impact factor: 2.386

5.  Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis.

Authors:  S Abrahams; L H Goldstein; A Al-Chalabi; A Pickering; R G Morris; R E Passingham; D J Brooks; P N Leigh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-05       Impact factor: 10.154

Review 6.  Sleep in patients with amyotrophic lateral sclerosis.

Authors:  J Hetta; I Jansson
Journal:  J Neurol       Date:  1997-04       Impact factor: 4.849

7.  Treatment of respiratory failure during sleep in patients with neuromuscular disease. Positive-pressure ventilation through a nose mask.

Authors:  E R Ellis; P T Bye; J W Bruderer; C E Sullivan
Journal:  Am Rev Respir Dis       Date:  1987-01

8.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

9.  Frontal lobe-related cognitive functions in patients with sleep apnea syndrome before and after treatment.

Authors:  C Feuerstein; B Naegelé; J L Pépin; P Lévy
Journal:  Acta Neurol Belg       Date:  1997-06       Impact factor: 2.396

10.  Cognitive impairment in motor neuron disease.

Authors:  R Gallassi; P Montagna; C Ciardulli; S Lorusso; V Mussuto; A Stracciari
Journal:  Acta Neurol Scand       Date:  1985-06       Impact factor: 3.209

View more
  25 in total

Review 1.  The management of motor neurone disease.

Authors:  P N Leigh; S Abrahams; A Al-Chalabi; M-A Ampong; L H Goldstein; J Johnson; R Lyall; J Moxham; N Mustfa; A Rio; C Shaw; E Willey
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

2.  Home mechanical ventilation: a Canadian Thoracic Society clinical practice guideline.

Authors:  Douglas A McKim; Jeremy Road; Monica Avendano; Steve Abdool; Fabien Cote; Nigel Duguid; Janet Fraser; Fracois Maltais; Debra L Morrison; Colleen O'Connell; Basil J Petrof; Karen Rimmer; Robert Skomro
Journal:  Can Respir J       Date:  2011 Jul-Aug       Impact factor: 2.409

Review 3.  Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials.

Authors:  Paul H Gordon
Journal:  Aging Dis       Date:  2013-10-01       Impact factor: 6.745

4.  [Noninvasive intermittent self ventilation in chronic respiratory insufficiency].

Authors:  O Karg
Journal:  Internist (Berl)       Date:  2003-01       Impact factor: 0.743

Review 5.  Amyotrophic lateral sclerosis: pathophysiology, diagnosis and management.

Authors:  Paul H Gordon
Journal:  CNS Drugs       Date:  2011-01       Impact factor: 5.749

6.  Mechanisms of improvement of respiratory failure in patients with restrictive thoracic disease treated with non-invasive ventilation.

Authors:  A H Nickol; N Hart; N S Hopkinson; J Moxham; A Simonds; M I Polkey
Journal:  Thorax       Date:  2005-06-06       Impact factor: 9.139

7.  Frontotemporal white matter changes in amyotrophic lateral sclerosis.

Authors:  Sharon Abrahams; Laura H Goldstein; John Suckling; Virginia Ng; Andy Simmons; Xavier Chitnis; Louise Atkins; Steve C R Williams; P N Leigh
Journal:  J Neurol       Date:  2005-03-03       Impact factor: 4.849

8.  Measuring reliable change in cognition using the Edinburgh Cognitive and Behavioural ALS Screen (ECAS).

Authors:  Christopher Crockford; Judith Newton; Katie Lonergan; Caoifa Madden; Iain Mays; Meabhdh O'Sullivan; Emmet Costello; Marta Pinto-Grau; Alice Vajda; Mark Heverin; Niall Pender; Ammar Al-Chalabi; Orla Hardiman; Sharon Abrahams
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2017-12-07       Impact factor: 4.092

Review 9.  The management of amyotrophic lateral sclerosis.

Authors:  Julie Phukan; Orla Hardiman
Journal:  J Neurol       Date:  2009-02-17       Impact factor: 4.849

10.  Early treatment with noninvasive positive pressure ventilation prolongs survival in Amyotrophic Lateral Sclerosis patients with nocturnal respiratory insufficiency.

Authors:  Pierluigi Carratù; Lucia Spicuzza; Anna Cassano; Mauro Maniscalco; Felice Gadaleta; Donato Lacedonia; Cristina Scoditti; Ester Boniello; Giuseppe Di Maria; Onofrio Resta
Journal:  Orphanet J Rare Dis       Date:  2009-03-10       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.